Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 10/20 | 0.51 |
| ▸ | MEN1 | O00255 | 7/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | PARP1 | P09874 | 8/20 | 0.46 |
| ▸ | CRHBP | P24387 | 1/20 | 0.43 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8685888 | 0.87 | KMT2A (0.40) | KMT2AMEN1MAPTPOLBGAA | |
| SCHEMBL8686383 | 0.87 | PARP1 (0.61) | KMT2AMEN1MAPTALDH1A1LMNA | |
| SCHEMBL8686384 | 0.87 | PARP1 (0.61) | KMT2AMEN1MAPTALDH1A1LMNA | |
| SCHEMBL8686377 | 0.82 | PARP1 (0.50) | KMT2AMEN1MAPTPOLBGAA | |
| SCHEMBL8685538 | 0.82 | PARP1 (0.63) | KMT2AMEN1MAPTPOLBALDH1A1 | |
| SCHEMBL8809303 | 0.77 | PARP1 (0.48) | KMT2AMEN1MAPTPOLBGAA | |
| SCHEMBL8810770 | 0.77 | MEN1 (0.51) | KMT2AMEN1MAPTPOLBGAA | |
| SCHEMBL8812780 | 0.77 | PARP1 (0.62) | KMT2AMEN1MAPTPOLBGAA | |
| SCHEMBL12892091 | 0.76 | KMT2A (0.66) | KMT2AMEN1MAPTPOLBALDH1A1 | |
| SCHEMBL1249238 | 0.76 | KMT2A (0.66) | KMT2AMEN1MAPTPOLBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5811439-A | ANTIDIABETIC AGENTS; SIDE EFFECT REDUCTION; ANTILEPEMIC AGENTS | SENGA PHARMACEUTICAL LABORATORY INC. (JP) | 1998-09-22 | — | — | US | disclosed |
| EP-0780389-A1 | Thiazolidinedione derivatives, process for their preparation and pharmaceutical compositions containing them | TOBISHI PHARMACEUTICAL CO., LTD. (JP) | 1997-06-25 | — | — | EP | disclosed |